共有 1 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R025811-10mg | 10mg | 现货 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-... N-[3-tert-Butyl-1-(quinolin-... |
98% |
|
|
| 罗恩 | R025811-50mg | 50mg | 现货 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-... N-[3-tert-Butyl-1-(quinolin-... |
98% |
|
|
| 罗恩 | R025811-1mg | 1mg | 现货 |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-... N-[3-tert-Butyl-1-(quinolin-... |
98% |
|
|
| 阿拉丁 | D126373-10mg | 10mg | 现货 |
DCC-2036 (Rebastinib),抑制剂 DCC-2036 (Rebastinib) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | D126373-50mg | 50mg | 现货 |
DCC-2036 (Rebastinib),抑制剂 DCC-2036 (Rebastinib) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R408600-1ml | 1ml | 现货 |
Rebastinib (DCC-2036) Rebastinib (DCC-2036) |
Moligand™, 10mM in DMSO |
|
|
| 阿拉丁 | D126373-5mg | 5mg | 现货 |
DCC-2036 (Rebastinib),抑制剂 DCC-2036 (Rebastinib) |
Moligand™, ≥98% |
|
|
| 毕得 | BD280341-50mg | 50mg | 现货 |
4-(4-(3-(3-(叔丁基)-1-(喹啉-6-基)-... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
98% |
|
|
| 毕得 | BD280341-100mg | 100mg | 现货 |
4-(4-(3-(3-(叔丁基)-1-(喹啉-6-基)-... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
98% |
|
|
| 韶远 | SY259195-0.25g | 0.25g | 现货 |
4-[4-[3-[3-(叔丁基)-1-(6-喹啉基)-5... 4-[4-[3-[3-(tert-Butyl)-1-(6... |
>97% |
|
|
| Matrix | MA147692-1g | 1g | 3-4周 |
4-(4-(3-(3-(tert-Butyl)-1-(q... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
95% | 咨询 | 请联系客服购买! |
| Matrix | MA147692-5g | 5g | 3-4周 |
4-(4-(3-(3-(tert-Butyl)-1-(q... 4-(4-(3-(3-(tert-Butyl)-1-(q... |
95% | 咨询 | 请联系客服购买! |
| solarbio | IR0640-5mg | 5mg | 请咨询 | Rebastini |
|
|
|
| solarbio | IR0640-10mg | 10mg | 请咨询 | Rebastini |
|
|
|
| solarbio | IR0640-50mg | 50mg | 请咨询 | Rebastini |
|
|
|
| solarbio | IR0640-25mg | 25mg | 请咨询 | Rebastini |
|
|
|
| solarbio | IR0640-1mg | 1mg | 请咨询 | Rebastini |
|
|
|
| solarbio | IR06409-1ml | 1ml | 请咨询 | Rebastinib(10mM in DMSO) |
|
|
|
| solarbio | IR06401-1ml | 1ml | 请咨询 | Rebastinib(10mM in DMSO,无菌) |
|
|
|
| 安耐吉 | M0151195-10mg | 10mg | 现货 |
DCC-2036 4-(4-(3-(3-(tert-butyl)-1-(q... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0151195-1mg | 1mg | 现货 |
DCC-2036 4-(4-(3-(3-(tert-butyl)-1-(q... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0151195-50mg | 50mg | 现货 |
DCC-2036 4-(4-(3-(3-(tert-butyl)-1-(q... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0151195-5mg | 5mg | 现货 |
DCC-2036 4-(4-(3-(3-(tert-butyl)-1-(q... |
Reference Standards, 98% |
|
|
| 源叶 | S80026-5mg | 5mg | 现货 |
DCC-2036 (Rebastinib) DCC-2036 (Rebastinib) |
≥99% |
|
|
| 源叶 | S80026-10mg | 10mg | 现货 |
DCC-2036 (Rebastinib) DCC-2036 (Rebastinib) |
≥99% |
|
|
| 源叶 | S80026-50mg | 50mg | 现货 |
DCC-2036 (Rebastinib) DCC-2036 (Rebastinib) |
≥99% |
|
|
| 源叶 | T92994-1ml | 1ml | 现货 |
Rebastinib (DCC-2036) Rebastinib (DCC-2036) |
10mM in DMSO |
|
|
| Target Mol | T2640-1mg | 1 mg | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Target Mol | T2640-5mg | 5 mg | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Target Mol | T2640-10mg | 10 mg | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Target Mol | T2640-50mg | 50 mg | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Target Mol | T2640-100mg | 100 mg | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Target Mol | T2640-25mg | 25 mg | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Target Mol | T2640-1mLx10mM(inDMSO) | 1 mL x 10 mM (in DMSO) | 现货 |
化合物 DCC-2036 Rebastini |
99.61% |
|
|
| Combi | QJ-8369-100mg | 100mg | 请咨询 |
Dcc-2036 Dcc-2036 |
95% | 咨询 | 请联系客服购买! |
| Combi | QJ-8369-250mg | 250mg | 请咨询 |
Dcc-2036 Dcc-2036 |
95% | 咨询 | 请联系客服购买! |
| Combi | QJ-8369-1g | 1g | 请咨询 |
Dcc-2036 Dcc-2036 |
95% | 咨询 | 请联系客服购买! |
| MCE | HY-13024-50mg | 50mg | 现货 |
Rebastinib Rebastini |
99.91% |
|
|
| MCE | HY-13024-10mg | 10mg | 现货 |
Rebastinib Rebastini |
99.91% |
|
|
| MCE | HY-13024-10mM*1mL | 10mM*1mL | 现货 |
Rebastinib Rebastini |
99.91% |
|
|
| MCE | HY-13024-5mg | 5mg | 现货 |
Rebastinib Rebastini |
99.91% |
|
|
| MCE | HY-13024-1mg | 1mg | 现货 |
Rebastinib Rebastini |
99.91% |
|
|